190 related articles for article (PubMed ID: 36268143)
21. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
22. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
Nie D; Zhang L; Wang C; Guo Q; Mao X
Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Role of the C-Reactive Protein/Albumin Ratio in Patients With Gynecological Cancers: A Meta-Analysis.
Fang Y; Zheng T; Zhang C
Front Oncol; 2021; 11():737155. PubMed ID: 34778051
[TBL] [Abstract][Full Text] [Related]
24. C-reactive Protein Is a Predictor of Prognosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
Liao DW; Hu X; Wang Y; Yang ZQ; Li X
Ann Clin Lab Sci; 2020 Mar; 50(2):161-171. PubMed ID: 32366552
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients.
Kankkunen E; Penttilä P; Peltola K; Bono P
Acta Oncol; 2022 Oct; 61(10):1240-1247. PubMed ID: 35905053
[TBL] [Abstract][Full Text] [Related]
26. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
Ji Y; Wang H
World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of C-Reactive Protein to Albumin Ratio in Gastric Cancer: A Meta-Analysis.
Yue L; Lu Y; Li Y; Wang Y
Nutr Cancer; 2021; 73(10):1864-1871. PubMed ID: 32940549
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis.
Yu X; Zhang X
Biomark Med; 2024 Apr; ():. PubMed ID: 38639733
[No Abstract] [Full Text] [Related]
30. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
31. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the expression of metastasis-associated in colon cancer-1 in gynecologic cancers and breast cancer: A protocol for systematic review and meta-analysis.
Wang L; Fan L; Xu H; Jiang H
Medicine (Baltimore); 2021 Feb; 100(8):e24255. PubMed ID: 33663046
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
Gao N; Yang RN; Meng Z; Wang WH
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan KT; Schlick K; Deutsch A; Melchardt T; Egle A; Stojakovic T; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Pichler M
Br J Cancer; 2014 Jul; 111(1):55-60. PubMed ID: 24874478
[TBL] [Abstract][Full Text] [Related]
35. Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder.
Eggers H; Seidel C; Schrader AJ; Lehmann R; Wegener G; Kuczyk MA; Steffens S
Med Oncol; 2013 Dec; 30(4):705. PubMed ID: 24005810
[TBL] [Abstract][Full Text] [Related]
36. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract][Full Text] [Related]
37. Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Absenger G; Stotz M; Samonigg H; Maurer-Ertl W; Stojakovic T; Ploner F; Leithner A; Pichler M
Br J Cancer; 2013 Oct; 109(9):2316-22. PubMed ID: 24084772
[TBL] [Abstract][Full Text] [Related]
38. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.
Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C
Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503
[TBL] [Abstract][Full Text] [Related]
40. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
